Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
JCO Glob Oncol. 2020 Mar;6:462-470. doi: 10.1200/JGO.19.00330.
JCO Glob Oncol. 2020.
PMID: 32196388
Free PMC article.
Complementary and alternative medicine (CAM) in Mexican patients with cancer.
Gerson-Cwilich R, Serrano-Olvera A, Villalobos-Prieto A.
Gerson-Cwilich R, et al. Among authors: villalobos prieto a.
Clin Transl Oncol. 2006 Mar;8(3):200-7. doi: 10.1007/s12094-006-0011-2.
Clin Transl Oncol. 2006.
PMID: 16648120
Review.
Item in Clipboard
[Clinicopathological features, prognosis and influence in the adjuvant treatment of the risk recurrence groups determined by the 21 gene expression profile, Oncotype Dx®, in early breast cancer].
Gerson Cwilich R, Alban de la Torre LF, Villalobos Prieto A, Serrano Olvera JA.
Gerson Cwilich R, et al. Among authors: villalobos prieto a.
Gac Med Mex. 2012 Mar-Apr;148(2):117-24.
Gac Med Mex. 2012.
PMID: 22622310
Free article.
Spanish.
Item in Clipboard
Severe thyrotoxicosis as initial presentation of gastric choriocarcinoma: a case report.
Iñiguez-Ariza NM, Cuenca D, Franco-Granillo J, Villalobos-Prieto A, Pineda-Díaz J, Baquera-Heredia J.
Iñiguez-Ariza NM, et al. Among authors: villalobos prieto a.
J Med Case Rep. 2022 Apr 21;16(1):159. doi: 10.1186/s13256-022-03343-5.
J Med Case Rep. 2022.
PMID: 35443720
Free PMC article.
Item in Clipboard
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators.
Powles T, et al.
Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21.
Lancet Oncol. 2020.
PMID: 32971005
Clinical Trial.
Item in Clipboard
[Haemorrhagic brain metastasis from prostatic adenocarcinoma].
Cuesta Mejías TC, Revilla Pacheco F, Gómez Reguera L, Salgado Lujambio P, García Ortiz R, Salgado Salgado G, Villalobos Prieto A.
Cuesta Mejías TC, et al. Among authors: villalobos prieto a.
Rev Neurol. 2004 Mar 16-31;38(6):537-40.
Rev Neurol. 2004.
PMID: 15054718
Free article.
Spanish.
Item in Clipboard
Cite
Cite